UEL’s ambition is to become London’s leading university for civic engagement. We are a vibrant and diverse university located in the heart of east London. Our new corporate plan sets an ambitious agenda for our future success and growth which focuses on the delivery of high quality teaching and learning, and excellence in research.
Suven Life Sciences Ltd (Suven) announces that the grant of one (1) product patent from China (CN103380131), one (1) product patent from Eurasia (9 Countries) (22043) and one (1) product patent from Hong Kong (HK 1180955)) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2032.